Trial intelligence / Profile preview

Nicotine Replacement Treatment for Pregnant Smokers

NCT00115687Phase 2Terminated

Sponsor
National Institute on Drug Abuse
Start
Jun 2002
Primary completion
Apr 2007
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Placebo with Nicotine Gum (2 arms). Primary endpoint: Biochemically validated quit rates. Started Jun 2002; status: terminated.

02

Drugs

nicotine polacrilex
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00115687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00115687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call